Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter to Pay $17M for Clinical Data's Cogenics Division

NEW YORK (GenomeWeb News) – Beckman Coulter has inked a definitive agreement to acquire the Cogenics division of Clinical Data for approximately $17 million, Clinical Data said after the close of the market on Wednesday.

Cogenics provides genomics services, such as DNA sequencing, gene expression, clinical and non-clinical genotyping, biomanufacturing support, nucleic acid extraction, and biobanking. Its services will complement those of Beckman's Agencourt Biosciences business, which also offers genomics services and nucleic acid purification products.

Under terms of the pact, Beckman will pay Clinical Data $15.4 million at the closing of the deal, which is expected this month. Clinical Data said that it also expects to retain around $2 million in cash from Cogenics immediately prior to the sale. In exchange, Beckman will acquire all of Cogenics' operations in the US, UK, France, and Germany.

Thomas Weisel Partners analyst Peter Lawson estimated in a research note that Cogenics brought in revenues of around $28 million for 2008.

Clinical Data intends to use the funds from the sale to support its late-stage therapeutic programs, including its phase III drug vilazodone for treating depression.

In addition to its drug business, Clinical Data continues to operate its PGx Health division, which is developing pharmacogenetic tests.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.